Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fate Therapeutics (FATE) Long-Term Investments (2019 - 2025)

Historic Long-Term Investments for Fate Therapeutics (FATE) over the last 7 years, with Q3 2025 value amounting to $10.3 million.

  • Fate Therapeutics' Long-Term Investments fell 6933.67% to $10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.3 million, marking a year-over-year decrease of 6933.67%. This contributed to the annual value of $27.7 million for FY2024, which is 272214.29% up from last year.
  • As of Q3 2025, Fate Therapeutics' Long-Term Investments stood at $10.3 million, which was down 6933.67% from $26.1 million recorded in Q2 2025.
  • In the past 5 years, Fate Therapeutics' Long-Term Investments registered a high of $149.5 million during Q2 2021, and its lowest value of $980000.0 during Q4 2023.
  • For the 5-year period, Fate Therapeutics' Long-Term Investments averaged around $42.7 million, with its median value being $26.9 million (2024).
  • As far as peak fluctuations go, Fate Therapeutics' Long-Term Investments crashed by 9509.06% in 2022, and later soared by 272214.29% in 2024.
  • Over the past 5 years, Fate Therapeutics' Long-Term Investments (Quarter) stood at $100.7 million in 2021, then tumbled by 95.09% to $4.9 million in 2022, then plummeted by 80.17% to $980000.0 in 2023, then surged by 2722.14% to $27.7 million in 2024, then crashed by 62.74% to $10.3 million in 2025.
  • Its Long-Term Investments stands at $10.3 million for Q3 2025, versus $26.1 million for Q2 2025 and $32.3 million for Q1 2025.